(Image caption: The brainstem of a myelin-deficient mouse that received a transplant of human OPCs a few days after birth and was then treated with the drug solifenacin. Daily treatment enhanced the capacity of human cells (labeled in green) to produce myelin (shown in red), which led to improved hearing in the mouse)

Myelin-maker: How an FDA-approved drug boosts myelin synthesis

Damage to myelin, the fatty insulator that enables communication between nerve cells, characterizes multiple sclerosis (MS) and other devastating neurological diseases.

The damage doesn’t come all at once: There is a“honeymoon” period during which some regeneration of myelin, called remyelination, does occur, but this ability to regenerate dissipates as the disease progresses and the patient ages.

Now, a University at Buffalo researcher has discovered a way to keep that kind of remyelination going, using a drug that’s already on the market.

A paper describing the research results was published this week in the Journal of Neuroscience.

“We have identified a new drug target that promotes stem cell therapy for myelin-based disease, such as MS,” says lead author Fraser J. Sim, PhD, assistant professor in the Department of Pharmacology and Toxicology in the University at Buffalo School of Medicine and Biomedical Sciences.

The study shows it is possible to boost myelination by targeting human oligodendrocyte progenitor cells with solifenacin, an anti-muscarinic drug that currently is approved and marketed to treat overactive bladder.

“Our hypothesis is that in MS, the oligodendrocyte progenitor cells seem to get stuck,” Sim explains. “When these cells don’t mature properly, they don’t differentiate into myelinating oligodendrocytes.”

In the new study, the approach Sim and his colleagues took was to first characterize the molecular pathways that govern the differentiation of human oligodendrocyte progenitor cells, and then identify drug candidates that would promote differentiation and myelin production.

They found that when a muscarinic type 3 receptor on human oligodendrocyte progenitor cells was activated, differentiation was completely blocked.

“So we thought, if we had something that blocks instead of activates this receptor, could we boost differentiation?” asks Fraser. To do that, the researchers turned to solifenacin, the anti-muscarinic drug for overactive bladder; the bladder muscle contains several muscarinic receptors.

“We were excited about this because solifenacin is an approved drug that’s already on the market,” says Sim.

To test whether the drug could boost myelin synthesis, the researchers transplanted human oligodendrocyte progenitor cells into mice that could not make myelin. The result was increased differentiation and myelin synthesis from the transplanted human cells.

But Sim and his colleagues needed a functional endpoint, a way to know that the myelin being made was being translated into improved behavior or function.

So Sim teamed up with Richard J. Salvi, PhD, SUNY Distinguished Professor in the Department of Communicative Disorders and Sciences, and director of UB’s Center for Hearing and Deafness.

Together, they determined that an auditory brainstem response, which records brain wave activity in response to sounds, would be appropriate.

Sim explains that it takes a certain amount of time for a signal to go from the ear to the front of the brain: “So in the readout, you get waves that should have a certain time pattern. When there isn’t enough myelin, the signaling slows down. And if you add myelin, you should see the signals speed up.”

The tests showed improvement in the response to auditory signals in animals transplanted with the human oligodendrocyte progenitor cells treated with solifenacin.

“We have identified a way to improve human myelination,” says Sim.

The promising results have prompted Sim and his colleagues to seek funding for a small human trial.

The study results are all preclinical and no human testing has been done yet.

Walk MS connects people living with MS and those who care about them.

I just registered to do the Walk MS on May 3rd. If any of you are from PA and would like to join the walk it is in Allentown at 10 AM.

If you would like to join my team or are willing to make a donation please visit the site. Funds go toward MS research and hopefully one day finding a cure!

2

Hello friends! At the end of June I will be embarking on the Ride For MS; Cape Cod Getaway to benefit the National MS Society! Over the next few months I will getting ready for the two day, 125 mile ride along the coast with 110,000 participates nationwide to raise awareness and resources for those effected. Your donations not only help researchers look for a cause but also funds programs such as support groups, medical care, and outreach.
This year I will be riding in support of Sara Swalnick who only recently was diagnosed with MS. She’s not letting this get her down! She’s participating in the Muck Fest for MS this summer in CO and our participation means that she and so many people like her will continue moving forward to find a cure.
On behalf of everyone going through rough diagnosis’s and on behalf of my team, Back Bay Cycling Club (B2C2) I thank everyone who participates and donates. It means the world and gives everyone a better crack at a good life.
Please visit my personal page to make a donation and share with your friends!
Thank you so much!
http://bikemam.nationalmssociety.org/goto/B2C2

John and Mary husband and

wife

bringing home a brand new

life

his name is 

Sammy

I’m big brother

Dean

the perfect family

or so it seemed

Looking into someone’s eyes can be a scary thing, but when you find the one whom ignites the spark. It’s like looking into your own soul.

M.S.